🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

💚Happy #WorldLiverDay! EASL Secretary General, Prof. Aleksander Krag’s highlights the urgent need for action in liver health on #WorldLiverDay. Most cases of liver disease are preventable. Early detection, lifestyle changes and public health measures are vital. Watch the

Join the #EASLStudio tomorrow at 13:15, live from Milan in the Hepatology Arena! "Advances in systemic treatments in liver cancer" features Josep Llovet (Icahn School of Medicine at Mount Sinai), massimo iavarone, Jessica Zucman-Rossi, and Matthias Pinter 📺Watch for free: easl.eu/studio-at-easl… #EASLCongress

Intense and active #HCC day at #EASL2024 Sherrie Bhoori Matthias Pinter Giuseppe Cabibbo Allaire Manon Guadalupe GarciaTsao Jean-Charles Nault Annalisa Berzigotti BCLC GROUP Lorenza Rimassa Eric Vibert et al 👌 science 🙌 provocative discussion 💪🙌 networking & frienship

#LiverTwitter, the wrap-up talks, summarising the best science presented at #EASLCongress, are now available for the full community through the Congress website! Watch them now: easlcongress.eu

🌟 What would you like to see at #EASLCongress 2025? We have launched SCOPE (Surveying Community Opinions for Programme Excellence), to ensure our next #EASLCongress meets the needs of all hepatology professionals. Join us in shaping a programme that fosters learning,

Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction - another piece of the puzzle by Claudia Angela M. Fulgenzi Surgery and Cancer UPO - Università jamanetwork.com/journals/jamao…

Original Article Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapy-based systemic therapy Scheiner et al. #LiverX journals.lww.com/hep/abstract/9…

A great multicentre study to boost new prospective studies: Matthias Pinter David James Pinato 🇺🇦 Lorenza Rimassa and the related Editorial The “shell game” after objective response in patients with advanced HCC... DOI: 10.1097/HEP.0000000000001130 Giuseppe Cabibbo Marco Sanduzzi Zamparelli

🌷#EASLCongress 2025 is taking place on 7-10 May in Amsterdam, the Netherlands and online. Only 1 week left for you to submit your abstract and get your work featured among 2500+ expected entries! Give your research visibility, don't miss the deadline! Submit by 3

🚨Reminder: Last chance to submit your abstract to #EASLCongress 2025! 🚨 Deadline: TOMORROW, 3 December 2024 🌷Share your work with the global hepatology community 🌷Engage with 8000+ experts and peers 🌷Be part of the programme! We look forward to receiving your research

🌷Join thousands of doctors, researchers, trainees, nurses, patient representatives, and industry partners as we come together to explore the future of hepatology at #EASLCongress 2025. 📅 7–10 May 2025 📍 RAI Amsterdam + Online ✅ A comprehensive scientific programme, from

EASLnews Governing Board meeting - working for the community❤️ 👉SLD and LCS summits 👉EASL schools / what and where? 👉EiC Journal of Hepatology JHEP Reports new initiatives🤩 👉 X vs bluesky ? 👉AI Task Force 👉#EASLCongress 2025 Amsterdam 👉Register grants 👉Global collaboration

📢 Perihilar CCA: A challenging tumour, accounting for 50–60% of all cholangiocarcinomas. 📍 Located in the bile ducts near the liver, its position and late presentation make diagnosis and treatment complex. 🧬 Learn more in the upcoming Molecular Tumour Board! 📅Wednesday, 29

💡 Unlock the complexities of perihilar cholangiocarcinoma at today's Molecular Tumour Board! Engage with leading experts to gain valuable insights and explore innovative treatment strategies. 📅 TODAY, 29 January | 18:00 CET 🔗easl-eu.zoom.us/webinar/regist… ℹ️ On-demand access is

👩‍⚕️ Are you involved in the fight against hepatocellular carcinoma? Then the EASL pre-congress event "Trial designs and endpoints in #HCC" taking place on 6 May is designed for YOU: ✅ Hepatologists ✅ Oncologists ✅ Surgeons ✅ Radiologists & Interventional oncologists ✅

🌷"Missing #EASLCongress would mean missing the year's most transformative liver disease insights!" - says our EASL External Affairs Councillor Francesco Paolo Russo Our programme this year promises 5 days of cutting edge science, knowledge sharing, and engaging with the liver community

#GUTOnline #GUTRecentAdvancesInClinicalPractice paper by Matthias Pinter et al entitled "Systemic treatment in patients with hepatocellular carcinoma and advanced liver dysfunction" via bit.ly/4m9umOO #HCC

Are you interested in building the future of hepatology with us? Do you have a strong scientific track record in Immune-mediated and Cholestatic Diseases? The EASL Scientific Committee is looking for one new member! Read more and apply by 15 June 23:59 CEST on:

#GUTImages from the #RecentAdvancesInClinicalPractice paper by Pinter (Matthias Pinter) et al on "Systemic treatment in patients with hepatocellular carcinoma and advanced liver dysfunction" via bit.ly/3SG5XTx David James Pinato 🇺🇦 #HCC